ClearBridge Investments’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-28
Closed -$22K 804
2020
Q2
$22K Sell
28
-42
-60% -$31.7K ﹤0.01% 840
2020
Q1
$42K Buy
70
+19
+37% +$18.5K ﹤0.01% 788
2019
Q4
$57K Sell
51
-36
-41% -$39.1K ﹤0.01% 814
2019
Q3
$104K Hold
87
﹤0.01% 763
2019
Q2
$144K Buy
87
+22
+34% +$38.1K ﹤0.01% 752
2019
Q1
$132K Buy
65
+10
+18% +$17.6K ﹤0.01% 770
2018
Q4
$70K Hold
55
﹤0.01% 823
2018
Q3
$104K Hold
55
﹤0.01% 838
2018
Q2
$111K Sell
55
-13
-19% -$29.6K ﹤0.01% 765
2018
Q1
$151K Hold
68
﹤0.01% 758
2017
Q4
$157K Sell
68
-10
-13% -$20.3K ﹤0.01% 760
2017
Q3
$138K Hold
78
﹤0.01% 758
2017
Q2
$106K Buy
78
+2
+3% +$2.41K ﹤0.01% 776
2017
Q1
$90K Hold
76
﹤0.01% 821
2016
Q4
$61K Buy
76
+1
+1% +$794 ﹤0.01% 868
2016
Q3
$66K Hold
75
﹤0.01% 842
2016
Q2
$42K Buy
75
+15
+25% +$8.49K ﹤0.01% 879
2016
Q1
$33K Buy
60
+6
+11% +$3.69K ﹤0.01% 902
2015
Q4
$45K Buy
54
+9
+20% +$8.99K ﹤0.01% 925
2015
Q3
$50K Sell
45
-10
-18% -$18.2K ﹤0.01% 962
2015
Q2
$119K Buy
55
+42
+323% +$85.6K ﹤0.01% 886
2015
Q1
$21K Sell
13
-12
-48% -$15.8K ﹤0.01% 1047
2014
Q4
$30K Hold
25
﹤0.01% 1027
2014
Q3
$12K Hold
25
﹤0.01% 1091
2014
Q2
$12K Buy
25
+1
+4% +$321 ﹤0.01% 1103
2014
Q1
$7K Buy
24
+6
+33% +$1.82K ﹤0.01% 1102
2013
Q4
$5K Hold
18
﹤0.01% 1077
2013
Q3
$6K Buy
+18
New +$6.68K ﹤0.01% 1052

Other funds holding BLUE

ClearBridge Investments's BLUE Position: Q3 2020 in Review

ClearBridge Investments sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 28 shares — an estimated $22K sold.

ClearBridge Investments first reported a position in BLUE in Q3 2013 and held it in 28 quarters. The position peaked at $157K in Q4 2017. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

  • ClearBridge Investments reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
  • ClearBridge Investments sold 28 bluebird bio shares in Q3 2020, an estimated $22K.
  • ClearBridge Investments first reported a position in bluebird bio in Q3 2013 and held it in 28 quarters.
  • ClearBridge Investments's bluebird bio position peaked at $157K in Q4 2017.
  • 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.